Tag: infectious disease molecular diagnostics market forecast

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Infectious Disease Molecular Diagnostics Market CAGR Outlook And Future Development

The infectious disease molecular diagnostics market size has shown strong expansion in recent years. It is anticipated to increase from $30.46 billion in 2025 to $32.04 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. The growth observed in prior periods can be attributed to the rising occurrence of infectious diseases, developments in PCR and sequencing technologies, increased government funding for infectious disease research, a greater emphasis on early diagnosis, and the broadening of clinical laboratory facilities.

The infectious disease molecular diagnostics market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors driving this growth during the forecast period include the increasing adoption of AI-driven diagnostic instruments, a heightened need for swift and precise diagnostics, the development of healthcare infrastructure in emerging markets, a greater emphasis on personalized medicine, and the proliferation of home-based molecular diagnostic solutions. Key trends expected over this period involve the widespread adoption of rapid point-of-care diagnostics, a growing requirement for multiplex testing, the integration of molecular diagnostics with EHR systems, an expansion of infectious disease surveillance initiatives, and an enhanced focus on detecting antimicrobial resistance.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=15306483&type=smp&name=Infectious%20Disease%20Molecular%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Infectious Disease Molecular Diagnostics Market Development Factors: What’s Supporting Demand?

The rising occurrence of infectious diseases is anticipated to drive the expansion of the infectious disease molecular diagnostics market in the future. These diseases are ailments stemming from harmful microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals either directly or indirectly. The growing commonness of infectious diseases primarily results from globalization and a surge in travel, facilitating the swift cross-border dissemination of pathogens and transforming localized outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing infectious diseases by providing quick and precise identification of pathogens at their genetic level, thus promoting prompt diagnosis, specific treatment, and efficient containment of outbreaks. As an illustration, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, reported in November 2024 that tuberculosis (TB) cases in 2023 totaled 9,633, an increase from 8,332 in 2022, signifying a 15.6% rise in the number of cases. Consequently, the growing frequency of infectious diseases is fueling the expansion of the infectious disease molecular diagnostics market.

Infectious Disease Molecular Diagnostics Market Segment Analysis And Revenue Potential

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

Infectious Disease Molecular Diagnostics Market Transformation Trends: What Innovations Are Driving Change?

Major enterprises active within the infectious disease molecular diagnostics sector are concentrating on creating cutting-edge remedies, such as real-time polymerase chain reaction kits, to facilitate swift, precise, and high-volume identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits function as diagnostic instruments capable of amplifying and concurrently identifying particular genetic material from pathogens in real time, thereby enabling quick and accurate identification of infectious conditions. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, introduced its Applied Biosystems TaqPath polymerase chain reaction kits specifically designed for detecting infectious diseases within India. These kits represent rapid, highly sensitive multiplex diagnostic approaches that enable real-time polymerase chain reaction detection of infectious disease targets through a comprehensive process, spanning from ribonucleic acid extraction to the production of a diagnostic report, typically completed in less than 4 hours. Such kits are characterized by multiplexed assays that target various genomic regions of pathogens, incorporate internal process controls, and offer automated data interpretation, thereby minimizing user errors and enhancing the dependability of results.

Infectious Disease Molecular Diagnostics Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel‑Ortho Corporation, Sysmex Corporation, Bio‑Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

View The Full Infectious Disease Molecular Diagnostics Market Report:

https://thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Infectious Disease Molecular Diagnostics Market Geographic Distribution And Regional Opportunities

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Infectious Disease Molecular Diagnostics Market From 2026 To 2030?

The infectious disease molecular diagnostics market size has demonstrated strong growth in recent years. It is projected to expand from $30.46 billion in 2025 to $32.04 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. Historically, this growth is attributable to factors such as the increasing prevalence of infectious diseases, advancements in PCR and sequencing technologies, rising government funding for infectious disease research, greater awareness about early diagnosis, and the expansion of clinical laboratories.

The infectious disease molecular diagnostics market size is projected to experience consistent expansion over the upcoming years. It is expected to reach $38.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. This anticipated growth can be attributed to factors such as the increasing integration of AI-powered diagnostic instruments, a heightened need for swift and precise diagnostic methods, the development of healthcare infrastructure in emerging markets, a greater emphasis on individualized medical treatments, and the proliferation of molecular diagnostic solutions for home use. Key trends during this period are expected to include the widespread adoption of quick point-of-care diagnostics, an increasing requirement for multiplex assays, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the broadening scope of infectious disease monitoring initiatives, and a sharpened focus on identifying antimicrobial resistance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp

What Market Drivers Are Helping Shape The Infectious Disease Molecular Diagnostics Market Expansion?

The infectious disease molecular diagnostics market is projected to expand due to the growing occurrence of infectious diseases. These diseases are conditions resulting from disease-causing microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals directly or indirectly. The rising incidence of these illnesses is largely attributable to globalization and increased travel, facilitating the swift spread of pathogens across regions and transforming local outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing these conditions by offering quick, precise pathogen detection at the genetic level, which assists in early detection, focused therapies, and successful outbreak containment. As an illustration, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, reported in November 2024 that tuberculosis (TB) cases in 2023 reached 9,633, an increase from 8,332 in 2022, signifying a 15.6% rise in cases. Consequently, the increasing prevalence of infectious diseases is fueling the expansion of the infectious disease molecular diagnostics market.

What Key Segment Areas Are Included In The Infectious Disease Molecular Diagnostics Market Assessment?

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

Which Trends Are Shaping The Infectious Disease Molecular Diagnostics Market Landscape?

Major companies engaged in the infectious disease molecular diagnostics market are concentrating on developing innovative solutions, such as real-time polymerase chain reaction kits, to enable the rapid, accurate, and high-throughput identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits function as diagnostic instruments that amplify and simultaneously detect specific genetic material of pathogens in real time, thereby allowing for quick and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, launched Applied Biosystems TaqPath polymerase chain reaction kits designed for detecting infectious diseases in India. These kits are fast, highly sensitive multiplex diagnostic solutions that facilitate real-time polymerase chain reaction detection of infectious disease targets using a complete workflow, from ribonucleic acid extraction to diagnostic report generation, typically in under 4 hours. Key features of these kits include multiplexed assays that target multiple genomic regions of pathogens, the incorporation of internal process controls, and automated data interpretation, which collectively reduce user error and enhance result reliability.

Which Companies Form The Competitive Landscape Of The Infectious Disease Molecular Diagnostics Market?

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Access The Complete Infectious Disease Molecular Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

Which Region Has The Strongest Presence In The Infectious Disease Molecular Diagnostics Market?

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Infectious Disease Molecular Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Prevention Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Infectious Disease Molecular Diagnostics Market Between 2026 And 2030?

The infectious disease molecular diagnostics market has experienced robust expansion over recent years. Projections indicate a rise from $30.46 billion in 2025 to $32.04 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. This historical growth can be linked to the increasing occurrence of infectious diseases, progress in PCR and sequencing technologies, augmented government investment in infectious disease research, heightened recognition of the importance of early diagnosis, and the proliferation of clinical laboratories.

The infectious disease molecular diagnostics market is anticipated to experience consistent expansion in the coming years. This market is projected to reach $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Several factors contribute to this growth during the forecast period, including the increasing integration of AI-driven diagnostic instruments, a heightened need for quick and precise diagnostic methods, the development of healthcare infrastructure in emerging markets, a stronger emphasis on personalized medical treatments, and the proliferation of at-home molecular diagnostic products. Key trends anticipated over this period encompass the widespread use of rapid point-of-care diagnostics, an increasing requirement for multiplex testing, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the broadening scope of infectious disease surveillance initiatives, and a sharpened focus on identifying antimicrobial resistance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp

What Leading Drivers Are Supporting The Infectious Disease Molecular Diagnostics Market Expansion?

The increasing occurrence of infectious diseases is projected to stimulate the expansion of the infectious disease molecular diagnostics market. These diseases are defined as illnesses resulting from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals. The heightened prevalence of infectious diseases stems primarily from globalization and increased travel, enabling pathogens to disseminate rapidly across borders and transform localized outbreaks into global health emergencies. Infectious disease molecular diagnostics play a crucial role in managing these conditions by facilitating the swift and accurate detection of pathogens at the genetic level, which in turn supports early diagnosis, targeted therapeutic approaches, and effective containment of outbreaks. For instance, in November 2024, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, stated that tuberculosis (TB) cases in 2023 reached 9,633, an increase from 8,332 in 2022, representing a 15.6% rise in the case count. Thus, the escalating prevalence of infectious diseases is a key factor driving the growth of the infectious disease molecular diagnostics market.

What Are The Key Segment Divisions In The Infectious Disease Molecular Diagnostics Market Segment Structure?

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

What Emerging Trends Are Seen In The Infectious Disease Molecular Diagnostics Market?

Major corporations within the infectious disease molecular diagnostics sector are concentrating their efforts on creating advanced solutions, such as real-time polymerase chain reaction kits, to facilitate swift, precise, and high-volume identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits serve as diagnostic instruments that magnify and concurrently identify particular genetic material from pathogens instantly, thus allowing for the quick and accurate diagnosis of infectious illnesses. For example, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, introduced its Applied Biosystems TaqPath polymerase chain reaction kits in India, designed for detecting infectious diseases. These kits represent rapid, highly sensitive multiplex diagnostic options that enable real-time polymerase chain reaction detection of infectious disease targets through a comprehensive process, from ribonucleic acid extraction to the generation of a diagnostic report, typically completed in under 4 hours. These solutions incorporate multiplexed assays aimed at various genomic regions of pathogens, include integrated process controls, and offer automated data analysis, thereby minimizing user mistakes and improving the dependability of results.

Which Organizations Are Engaged In The Infectious Disease Molecular Diagnostics Market?

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Get The Full Infectious Disease Molecular Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

Which Region Is The Leading Market For The Infectious Disease Molecular Diagnostics Market?

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Infectious Disease Molecular Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Prevention Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Infectious Disease Molecular Diagnostics Market At The End Of The 2026–2030 Forecast Period?

The infectious disease molecular diagnostics market size has exhibited robust growth in recent years. It is anticipated to expand from $30.46 billion in 2025 to $32.04 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. This historical advancement can be attributed to the rising occurrence of infectious diseases, innovations in PCR and sequencing technologies, increased government investment in infectious disease research, heightened awareness regarding early diagnosis, and the proliferation of clinical laboratories.

The infectious disease molecular diagnostics market is projected to experience consistent expansion in the coming years. This market is anticipated to reach $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the projected period include the increasing integration of AI-powered diagnostic instruments, a heightened need for quick and precise diagnostic methods, the improvement of healthcare infrastructure in developing economies, a greater emphasis on individualized medical treatments, and the proliferation of at-home molecular diagnostic products. Key trends anticipated for the forecast timeframe encompass the widespread embrace of rapid point-of-care diagnostics, an escalating requirement for multiplex testing capabilities, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the broadening of infectious disease monitoring initiatives, and a stronger emphasis on identifying antimicrobial resistance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp

What Drivers Are Shaping The Future Growth Of The Infectious Disease Molecular Diagnostics Market?

The future expansion of the infectious disease molecular diagnostics market is anticipated to be spurred by the growing occurrence of infectious diseases. These illnesses originate from pathogenic microbes like bacteria, viruses, fungi, or parasites, transferable either directly or indirectly between individuals. A primary factor behind the increased incidence of infectious diseases is globalization and the rise in travel, which allows disease-causing agents to quickly disseminate globally, transforming local outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing these conditions by providing swift and precise identification of pathogens at their genetic level, thus assisting in prompt diagnosis, focused therapies, and successful containment of outbreaks. As an illustration, in November 2024, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that tuberculosis (TB) cases in 2023 totaled 9,633, an increase from 8,332 in 2022, representing a 15.6% rise in the number of cases. Consequently, the rising frequency of infectious diseases is fostering the development of the infectious disease molecular diagnostics market.

What Segment Types Make Up The Infectious Disease Molecular Diagnostics Market?

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

Which Market Trends Are Creating New Opportunities In The Infectious Disease Molecular Diagnostics Market?

Major companies within the infectious disease molecular diagnostics market are focusing on developing innovative solutions, such as real-time polymerase chain reaction kits, to enable rapid, accurate, and high-throughput detection of infectious pathogens. Real-time polymerase chain reaction (PCR) kits are diagnostic tools that amplify and simultaneously detect specific genetic material of pathogens in real time, allowing for rapid and accurate identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, launched Applied Biosystems TaqPath polymerase chain reaction kits designed for the detection of infectious diseases in India. These kits are fast, highly sensitive multiplex diagnostic solutions that enable real-time polymerase chain reaction detection of infectious disease targets using a complete workflow from ribonucleic acid extraction to diagnostic report generation, typically in under 4 hours. These kits feature multiplexed assays targeting multiple genomic regions of pathogens, include internal process controls, and provide automated data interpretation, reducing user error and enhancing result reliability.

Who Are The Key Players Driving Competition In The Infectious Disease Molecular Diagnostics Market?

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Read the full infectious disease molecular diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

Which Geographic Regions Are Influencing Demand In The Infectious Disease Molecular Diagnostics Market?

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infectious Disease Molecular Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Prevention Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Infectious Disease Molecular Diagnostics Market between 2026 and 2030?

The infectious disease molecular diagnostics market has experienced significant expansion in recent years. Its valuation is anticipated to increase from $30.46 billion in 2025 to $32.04 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.2%. This historical development can be ascribed to several factors, including the rising occurrence of infectious diseases, breakthroughs in PCR and sequencing technologies, augmented government financial support for infectious disease research, a heightened understanding of the benefits of early diagnosis, and the growth of clinical laboratories.

The market for infectious disease molecular diagnostics is projected to experience consistent expansion in the coming years. This market is anticipated to reach a valuation of $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Several factors will fuel this growth during the forecast period, including the increasing integration of AI-powered diagnostic tools, a surge in the need for quick and precise diagnostics, the development of healthcare infrastructure in emerging markets, a heightened emphasis on personalized medical approaches, and the proliferation of at-home molecular diagnostic solutions. Key trends anticipated within this timeframe involve the widespread embrace of rapid point-of-care diagnostics, an escalating requirement for multiplex testing, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the expansion of initiatives for infectious disease surveillance, and a growing emphasis on identifying antimicrobial resistance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Infectious Disease Molecular Diagnostics Market?

The future expansion of the infectious disease molecular diagnostics market is anticipated to be driven by the rising occurrence of infectious diseases. These diseases are ailments resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals. The escalating incidence of infectious diseases largely stems from globalization and heightened travel, which facilitates the swift cross-border dissemination of pathogens, transforming localized outbreaks into worldwide health crises. By providing quick and precise identification of pathogens at their genetic level, infectious disease molecular diagnostics aid in managing infectious diseases, thereby promoting prompt diagnosis, precise treatment, and successful control of outbreaks. As an illustration, the US Centers for Disease Control and Prevention (CDC), a US-based government body, reported in November 2024 that tuberculosis (TB) cases in 2023 climbed to 9,633 from 8,332 in 2022, representing a 15.6% rise in the number of cases. Consequently, the expanding occurrence of infectious diseases is a key factor propelling the growth of the infectious disease molecular diagnostics market.

How Is The Infectious Disease Molecular Diagnostics Market Organized Into Various Segments?

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

How Are Emerging Trends Affecting The Progression Of The Infectious Disease Molecular Diagnostics Market?

Leading companies active in the infectious disease molecular diagnostics market are concentrating on creating innovative solutions, such as real-time polymerase chain reaction kits, to enable the rapid, accurate, and high-throughput identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits are diagnostic instruments designed to amplify and concurrently detect specific genetic material of pathogens in real time, thereby allowing for the prompt and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, introduced Applied Biosystems TaqPath polymerase chain reaction kits, specifically developed for the detection of infectious diseases in India. These kits represent fast, highly sensitive multiplex diagnostic solutions that facilitate real-time polymerase chain reaction detection of infectious disease targets using a comprehensive workflow, from ribonucleic acid extraction to diagnostic report generation, typically completed in under 4 hours. Furthermore, these kits incorporate multiplexed assays targeting multiple genomic regions of pathogens, include internal process controls, and provide automated data interpretation, which reduces user error and enhances the reliability of the results.

Who Are The Major Companies Operating In The Infectious Disease Molecular Diagnostics Market?

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Infectious Disease Molecular Diagnostics Market?

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Infectious Disease Molecular Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company

Infection Control Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Infection Prevention Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Hospital Acquired Infection Control Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Infectious Disease Molecular Diagnostics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The infectious disease molecular diagnostics market size has experienced robust expansion in recent years. It is projected to grow from $28.95 billion in 2024 to $30.46 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.2%. This market’s historical growth can be attributed to the increasing prevalence of infectious diseases, a rising demand for early and accurate diagnosis, the escalation of global outbreaks and pandemics, growing healthcare awareness and access, and increased investment in diagnostic research and technology.

The infectious disease molecular diagnostics market is anticipated to experience robust expansion over the coming years. This market is projected to reach $36.98 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the increasing uptake of point-of-care testing, a heightened emphasis on personalized medicine, greater governmental assistance for managing infectious diseases, the expansion of healthcare infrastructure in developing economies, and the rising occurrence of respiratory ailments. Key trends anticipated for this period encompass significant progress in real-time polymerase chain reaction technology, sophisticated incorporation of artificial intelligence into diagnostic platforms, the creation of multiplex testing panels, innovative portable and at-home diagnostic kits, and enhanced automation in molecular diagnostic procedures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp

Which Drivers Are Impacting The Infectious Disease Molecular Diagnostics Market?

The infectious disease molecular diagnostics market is anticipated to expand due to the growing occurrence of infectious diseases. These diseases are conditions resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of transmission between individuals through direct or indirect contact. A key factor contributing to this escalating prevalence is globalization and increased travel, which facilitates the swift international dissemination of pathogens, transforming isolated outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing infectious diseases through the prompt and precise genetic detection of pathogens, thereby assisting with early diagnosis, specific treatments, and efficient outbreak containment. An example is provided by the Centers for Disease Control and Prevention, a US-based government agency, which reported in November 2023 that the United States saw 8,331 tuberculosis (TB) cases in 2022, an increase of 5.9% compared to 2021. Consequently, the rising incidence of infectious diseases is a significant impetus for the growth of the infectious disease molecular diagnostics market.

What Are The Different Segment Classifications Within The Infectious Disease Molecular Diagnostics Market?

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Mass Spectrometry, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

Which Key Trends Are Expected To Influence The Infectious Disease Molecular Diagnostics Market In The Coming Years?

Key players in the infectious disease molecular diagnostics market are concentrating on creating advanced solutions, including real-time polymerase chain reaction kits, to facilitate the rapid, accurate, and high-throughput identification of infectious pathogens. These real-time polymerase chain reaction (PCR) kits function as diagnostic instruments, amplifying and concurrently detecting specific genetic material from pathogens in real time, which permits the swift and precise identification of infectious diseases. As an illustration, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, unveiled Applied Biosystems TaqPath polymerase chain reaction kits intended for the detection of infectious diseases in India. These kits offer fast, highly sensitive multiplex diagnostic capabilities, enabling real-time polymerase chain reaction detection of infectious disease targets via a comprehensive workflow, spanning from ribonucleic acid extraction to diagnostic report generation, typically completed in under 4 hours. The kits incorporate multiplexed assays aimed at various genomic regions of pathogens, include internal process controls, and deliver automated data interpretation, thereby minimizing user error and boosting result reliability.

Which Key Market Players Are Investing In Expansion And Innovation Of Infectious Disease Molecular Diagnostics Market?

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

How Does The Infectious Disease Molecular Diagnostics Market Perform Across Key Geographic Regions?

North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Infectious Disease Molecular Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2025, By The Business Research Company

Infection Control Supplies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Hospital Acquired Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Infectious Disease Molecular Diagnostics Sector?

In recent years, the molecular diagnostics market for infectious diseases has experienced significant growth. The market is projected to expand from $28.95 billion in 2024 to $30.46 billion in 2025, representing a compound annual growth rate (CAGR) of 5.2%. The historic growth of this market can be traced back to factors such as the higher occurrence of infectious diseases, growing need for swift and precise diagnosis, an upsurge in worldwide epidemics and pandemics, enhanced healthcare consciousness and accessibility, and an increase in funding for diagnostic research and technology.

The market size for molecular diagnostics in infectious diseases is projected to exhibit robust growth in the upcoming years. The expectation is an expansion to $36.98 billion by the year 2029, leveraging a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period can be credited to the increased adoption of point-of-care testing, an intensified emphasis on personalized medicine, escalating governmental backing for infectious disease management, the augmentation of healthcare infrastructure in developing markets, and the escalating incidences of respiratory diseases. The trends to watch out for in the forecast period include technological advancements in real-time polymerase chain reaction, significant integration of artificial intelligence into diagnostic platforms, development of multiplex testing panels, innovation in portable and home-based diagnostic kits, and evolution in automation of molecular diagnostic processes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp

What Forces Are Driving The Growth Of The Infectious Disease Molecular Diagnostics Market?

The growing incidence of infectious diseases is likely to drive the expansion of the infectious disease molecular diagnostics market. These diseases, which are caused by harmful microorganisms including bacteria, viruses, fungi, or parasites, can be transmitted either directly or indirectly between individuals. The surge in infectious diseases can be attributed mainly to globalisation and extensive travel, leading the pathogens to quickly cross borders and convert localised outbreaks into international health crises. Infectious disease molecular diagnostics aid disease management by accurately and swiftly detecting pathogens at a genetic level. This accelerates early diagnosis and specific treatment which optimises outbreak control. For instance, the United States documentated 8,331 tuberculosis cases in 2022, a 5.9% increase from 2021, as stated by the Centers for Disease Control and Prevention, a government in the US, in November 2023. Hence, the escalation of infectious diseases is stimulating the growth of the infectious disease molecular diagnostics market.

How Is The Infectious Disease Molecular Diagnostics Industry Segmented Across Key Parameters?

The infectious disease molecular diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments, Software And Services

2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Mass Spectrometry, Transcription Mediated Amplification, Other Technologies

3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications

4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits

2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

What Notable Trends Are Shaping The Direction Of The Infectious Disease Molecular Diagnostics Market?

Leading firms in the infectious disease molecular diagnostics market are striving to create cutting-edge solutions like real-time polymerase chain reaction kits. These kits serve as diagnostic instruments that amplify and simultaneously identify specific genetic materials of pathogens in ‘real time’. This paves the way for quick and precise identification of infectious diseases. For example, Thermo Fisher Scientific Inc., an American-based biotech and life science organization, introduced Applied Biosystems TaqPath polymerase chain reaction kits in India in February 2023. These kits, explicitly engineered for infectious disease detection, are fast, extremely sensitive multiplex diagnostic tools that facilitate real-time polymerase chain reaction identification of infectious disease targets. They carry out the spectrum of processes from ribonucleic acid extraction to diagnostic report formation, typically in under 4 hours. These kits incorporate multiplexed assays targeting diverse genomic areas of pathogens, include internal process controls, and provide automated data interpretation. This diminishes user error and elevates the reliability of the results.

Which Companies Currently Dominate The Competitive Landscape In The Infectious Disease Molecular Diagnostics Industry?

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report

Which Geographic Regions Are Driving Demand In The Infectious Disease Molecular Diagnostics Market?

North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model